Personalizing antidepressant choice by sex, body mass index, and symptom profile: An iSPOT-D report

Personalized Medicine in Psychiatry

Volumn 1-2, Issue , 2017, Pages 65-73

  Green, Erin ^a,b   Goldstein Piekarski, Andrea N ^a,b   Schatzberg, Alan F ^b   Rush, A John ^c   Ma, Jun ^d   Williams, Leanne ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ANXIETY DISORDER; APPETITE DISORDER; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; FEMALE; GUILT; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; OBESITY; OUTPATIENT; PSYCHOMOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEX; SLEEP DISORDER; SUICIDAL IDEATION; SYMPTOM; WORLD HEALTH ORGANIZATION;

EID: 85042878013     PISSN: 24681717     EISSN: 24681725     Source Type: Journal    
DOI: 10.1016/j.pmip.2016.12.001     Document Type: Article

References (28)

1. Baca E., Garcia-Garcia M., Porras-Chavarino A. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28(1):57-65.
2. Gaynes B.N., Warden D., Trivedi M.H., Wisniewski S.R., Fava M., Rush A.J. What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatr Serv 2009, 60(11):1439-1445.
3. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
4. Hildebrandt M.G., Steyerberg E.W., Stage K.B., Passchier J., Kragh-Soerensen P. Are gender differences important for the clinical effects of antidepressants?. Am J Psychiatry 2003, 160(9):1643-1650.
5. Khan A., Brodhead A.E., Schwartz K.A., Kolts R.L., Brown W.A. Sex differences in antidepressant response in recent antidepressant clinical trials. J Clin Psychopharmacol 2005, 25(4):318-324.
6. Khan A., Schwartz K.A., Kolts R.L., Brown W.A. BMI, sex, and antidepressant response. J Affect Disord 2007, 99(1-3):101-106.
7. Kloiber S., Ising M., Reppermund S., Horstmann S., Dose T., Majer M., et al. Overweight and obesity affect treatment response in major depression. Biol Psychiatry 2007, 62(4):321-326.
8. Kornstein S.G., Schatzberg A.F., Thase M.E., Yonkers K.A., McCullough J.P., Keitner G.I., et al. Gender differences in treatment response to sertraline versus imipramine in chronic depression. Am J Psychiatry 2000, 157(9):1445-1452.
9. Lin C.H., Chen C.C., Wong J., McIntyre R.S. Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder. J Affect Disord 2014, 161:123-126.
10. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010, 67(3):220-229.
11. McElroy S.L., Kotwal R., Malhotra S., Nelson E.B., Keck P.E., Nemeroff C.B. Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry 2004, 65(5):634-651. quiz 730.
12. Oskooilar N., Wilcox C.S., Tong M.L., Grosz D.E. Body mass index and response to antidepressants in depressed research subjects. J Clin Psychiatry 2009, 70(11):1609-1610.
13. Papakostas G.I., Petersen T., Iosifescu D.V., Burns A.M., Nierenberg A.A., Alpert J.E., et al. Obesity among outpatients with major depressive disorder. Int J Neuropsychopharmacol 2005, 8(1):59-63.
14. Parker G., Parker K., Austin M.P., Mitchell P., Brotchie H. Gender differences in response to differing antidepressant drug classes: two negative studies. Psychol Med 2003, 33(8):1473-1477.
15. Quitkin F.M., Stewart J.W., McGrath P.J., Taylor B.P., Tisminetzky M.S., Petkova E., et al. Are there differences between women's and men's antidepressant responses?. Am J Psychiatry 2002, 159(11):1848-1854.
16. Robinson W.D., Geske J.A., Prest L.A., Barnacle R. Depression treatment in primary care. J Am Board Fam Pract 2005, 18(2):79-86.
17. Sagud M., Hotujac L., Mihaljevic-Peles A., Jakovljevic M. Gender differences in depression. Coll Antropol 2002, 26(1):149-157.
18. Sagud M., Mihaljevic-Peles A., Uzun S., Cusa B.V., Kozumplik O., Kudlek-Mikulic S., et al. The lack of association between components of metabolic syndrome and treatment resistance in depression. Psychopharmacology 2013, 230(1):15-21.
19. Saveanu R., Etkin A., Duchemin A.M., Goldstein-Piekarski A., Gyurak A., Debattista C., et al. The international Study to Predict Optimized Treatment in Depression (iSPOT-D): outcomes from the acute phase of antidepressant treatment. J Psychiatr Res 2015, 61:1-12.
20. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998, 59(Suppl 20):22-33. quiz 34-57.
21. Thiels C., Linden M., Grieger F., Leonard J. Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. Int Clin Psychopharmacol 2005, 20(1):1-7.
22. Toups M.S., Myers A.K., Wisniewski S.R., Kurian B., Morris D.W., Rush A.J., et al. Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication. Psychosom Med 2013, 75(9):863-872.
23. Uher R., Mors O., Hauser J., Rietschel M., Maier W., Kozel D., et al. Body weight as a predictor of antidepressant efficacy in the GENDEP project. J Affect Disord 2009, 118(1-3):147-154.
24. Vogelzangs N., Beekman A.T., van Reedt Dortland A.K., Schoevers R.A., Giltay E.J., de Jonge P., et al. Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology 2014, 39(7):1624-1634.
25. Williams L.M., Rush A.J., Koslow S.H., Wisniewski S.R., Cooper N.J., Nemeroff C.B., et al. International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials 2011, 12:4.
26. Wohlfarth T., Storosum J.G., Elferink A.J., van Zwieten B.J., Fouwels A., van den Brink W. Response to tricyclic antidepressants: independent of gender?. Am J Psychiatry 2004, 161(2):370-372.
27. Woo Y.S., Seo H.J., McIntyre R.S., Bahk W.M. Obesity and its potential effects on antidepressant treatment outcomes in patients with depressive disorders: a literature review. Int J Mol Sci 2016, 17(1).
28. Young A.S., Klap R., Sherbourne C.D., Wells K.B. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry 2001, 58(1):55-61.